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Introduction
Eosinophilic pancreatitis (EP) is an extremely rare etiology of
chronic pancreatitis, and only a few cases have been reported
[1, 2]. It is characterized by diffuse or localized eosinophilic in-
filtration of the pancreas and elevated IgE levels. Differential di-
agnosis between EP and pancreatic cancer (PC) is challenging
because clinical symptoms and auxiliary exams (laboratory
tests and radiological evaluation) may be rather similar [3].
Routine endoscopic ultrasound-guided fine-needle aspira-
tion (EUS-FNA) for resectable pancreatic lesions is controversial
[4]. Some experts advocate that routine FNA may detect a non-
surgical condition and therefore avoid an unnecessary opera-
tion and related complications. Conversely, EUS-FNA presents
a substantial false-negative rate and may be associated with
some adverse events, which might postpone or impair a cur-
able resection [5, 6]. We report a case that illustrates the afore-
mentioned debate.
Case report
A 37-year-old man with a 4-month history of weight loss, ob-
structive jaundice, pruritus, and nausea and vomiting was ad-
mitted with an acute clinical complaint of fever, cough and dys-
pnea. He reported alcohol abuse for 15 years but denied any
family medical history of PC. Physical examination revealed
normal general appearance (body mass index=21 kg/m2) but
jaundice (2 +/4 +). Abdominal examination showed neither ab-
dominal pain nor palpable masses. Laboratory tests were as fol-
lows: hemoglobin, 12.1 g/L; leukocyte count, 9.3 ×109/L; neu-
trophils, 5.6 ×109 (56%); eosinophils: 0.12×109 (12%) (refer-
ence range: 0.0–0.06×109); total bilirubin 3.97mg/dL (direct
bilirubin: 3.52mg/dL); alkaline phosphatase, 769 U/L; gamma-
glutamyl transferase, 591 U/L; AST, 76 U/L; ALT, 72 U/L; and
normal CA, 19.9. Hepatitis serology and autoimmune tests
were negative.
Abdominal ultrasound showed biliary dilation but no cause
for obstruction. Magnetic resonance cholangiopancreatogra-
phy revealead biliary dilation due to an abrupt irregular narrow-
ing in the distal common bile duct (CBD) without evident lesion
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Background and study aims Eosinophilic pancreatitis
(EP) is a rare etiology of chronic pancreatitis, and few cases
have been reported. It is characterized by eosinophilic infil-
tration of the pancreas and elevated IgE levels. EP is difficult
to distinguish from pancreatic cancer based on clinical
symptoms and auxiliary exams. We present a case of EP
and debate the routine performance of endoscopic ultra-
sound-guided fine-needle aspiration (EUS-FNA) for resect-
able pancreatic mass.
Case report



















































associated with pancreatic body and tail atrophy and a normal
pancreatic duct. Finally, abdominal computed tomography (CT)
showed a 20-mm mass in the head of the pancreas, hypoatte-
nuating, with no vascular invasion (▶Fig. 1).
Endoscopic ultrasound (EUS) followed by endoscopic retro-
grade cholangiopancreatography (ERCP) to evaluate the mass
and perform biliary drainage was indicated. EUS demonstrated
a hypoechoic pancreatic head mass measuring 20mm and a
CBD dilatation. EUS-FNA was performed with a 22-gauge nee-
dle (Expect Slimline, Boston Scientific, Marlborough, Massachu-
setts, United States) but cytology was inconclusive.
ERCP demonstrated mild biliary duct dilatation due to a reg-
ular distal biliary stricture, suggesting pancreatic extrinsic com-
pression (▶Fig. 2a). Transpapillary forceps biopsy and brush
cytology were negative for malignancy. A 10 Fr × 7-cm plastic
stent placement ensured adequate CBD drainage (▶Fig. 2b).
After the negative sample results, a multidisciplinary group
discussed surgery versus a new attempt at EUS-FNA. An EUS-
FNA was indicated, and once again, we used a 22-gauge needle
(Expect Slimline, Boston Scientific, Marlborough, Massachu-
setts, United States). The new cytological evaluation showed
massive pancreatic eosinophilic infiltration without a consider-
able increase in the presence of IgG4 positive cells, consistent
with eosinophilic pancreatitis (▶Fig. 3).
After the diagnosis, the patient was also diagnosed with eo-
sinophilic pneumonia and treated with systemic corticosteroids
for 5 weeks.
Post-treatment contrast abdominal CT revealed mass shrink-
ing from 20mm to 12mm without biliary tract dilation
(▶Fig. 4). Repeat complete blood count showed no elevation
of serum IgG4 (121mg/dL), hemoglobin 16.0 g/L, leukocyte
count 8.3 ×109/L, neutrophils 4.6 ×109 (46%), eosinophils:
0.02×109 (2.0%), total bilirubin 0.37mg/dL, alkaline phospha-
tase 63U/L, and gamma-glutamyl transferase 132U/L.
At 1-year follow-up, the patient is asymptomatic on a low
dose of systematic corticosteroids even after biliary stent re-
moval.
▶ Fig. 1 EUS image showing a hypoechoic pancreatic head mass.
▶ Fig. 2 a ERCP showing a distal biliary stricture; b Biliary drainage
with 10 Fr ×7 cm plastic stent.
▶ Fig. 3 Cell block, hematoxylin-eosin staining, 400×Zoom, show-
ing eosinophils in the pancreas.
▶ Fig. 4 Post-treatment CT study revealing a mass shrinking and
no biliary dilation.





















































EP is a rare etiology of chronic pancreatitis characterized by lo-
calized or diffuse eosinophilic infiltration of the pancreas and
increased serum IgE [3]. Usually, the patient presents with a
pancreatic mass due to eosinophilic inflammatory infiltration
associated with obstructive jaundice, as in our case [2, 3].
Many etiologies for EP have been suggested and published
case reports include malignancy, parasitic infection, hypersen-
sitivity to medications (e. g., carbamazepine), milk allergy, ato-
pic diseases, newborn infant of a diabetic mother, and as an as-
sociation with hypereosinophilic syndrome or eosinophilic gas-
troenteritis [1, 7].
A diagnosis of EP is often made based on hypereosinophilic
syndrome or eosinophilic gastroenteritis criteria in patients
presenting with gastrointestinal symptoms who exhibit eosino-
philic infiltration in histological/cytological samples [3, 4, 8].
Diagnostic criteria for hypereosinophilic syndrome are as
follows: peripheral eosinophil count higher than 1.5×109 for 6
months; past medical history of rhinitis, asthma or other aller-
gic diseases; eosinophilic infiltration of other organs (digestive
system, skin and/or heart); nad exclusion of other causes for
eosinophilia such as parasitic infestations or leukemia [3, 8].
Regarding the eosinophilic gastroenteritis, which our pa-
tient had as well, the diagnostic criteria include presence of ab-
dominal pain, vomiting, nausea, diarrhea, loss of appetite or
any other digestive symptom; intestinal sampling showing eo-
sinophilic infiltration and ruling out parasitic infection; and no
involvement of organs outside the gastrointestinal tract [4].
The main differential diagnosis includes autoimmune pan-
creatitis (AIP) and PC [3].
EP is difficult to distinguish from AIP because they present
with similar clinical symptoms and radiologic results [3, 7].
However, subtle differences may favor one over the other. ▶Ta-
ble1 outlines characteristics that may help differentiate EP
from AIP.
Both EP and AIP are commonly misdiagnosed as PC due to
the similarity of symptoms and imaging findings. It is important
to recognize that some cases of PC are associated with eosino-
philia, which can make the diagnosis of either condition diffi-
cult [3].
Definitive diagnosis depends on histological/cytological
findings, assessment of serum tumor marker, absence of pan-
creatic duct dilation, history of hypereosinophilic syndrome or
eosinophilic gastroenteritis, and response to corticosteroid or/
and cromolyn therapy [4, 9].
Nearly 7% of patients undergoing pancreatoduodenectomy
for suspected malignancy are ultimately diagnosed with benign
disease. Although some preoperative findings such as abdomi-
nal pain, absence of jaundice, normal pancreatic duct and ab-
sence of a mass or double duct sign on CT might indicate a be-
nign condition, they are not sufficient to warrant use of conser-
vative therapy [9]. EUS-FNA is an essential procedure for a pa-
tient with suspected PC who does not fit the typical demo-
graphics/preoperative findings.
Most cases of EP are diagnosed postoperatively. To avoid
such unnecessary surgeries, adequate assessment of the pa-
tientʼs medical history and EUS-FNA for tissue sample are fun-
damental [3, 6]. In our case, even after a negative EUS-FNA, we
decided on another FNA because the patient was young and
well-appearing, and had no dilation of the main pancreatic
duct. However, only after the cytological results were we able
to correlate the findings of the patient's clinical history and la-
boratory tests and diagnosed the hypereosinophilic syndrome.
There are few reports in the literature of cases of eosinophi-
lic pancreatitis diagnosed by EUS-FNA [1, 8, 10]. As in our pa-
tient, adequate control of the disease was achieved using pre-
dnisolone or cromolyn [3, 10].
Conclusions
In summary, EP is a rare condition that is frequently misdiag-
nosed with PC. Clinical history, laboratory tests, radiological ex-
ams and tissue sampling are necessary for a definite diagnosis.
Correct and precise diagnosis is crucial and may prevent unne-
cessary surgery and allow for noninvasive treatment. EUS-FNA
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Autoimmune pancreatitis Eosinophilic pancreatitis
Aspect of the pancreas Enlarged pancreas (“sausage-like”) Focal or diffuse
Histopathological findings Lymphocytes Eosinophils
Immunoglobulins Elevated serum IgG4 Elevated serum IgE
Autoimmune and antinuclear antibodies (+) (–)
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